HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the...
Pharmaceutical
Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model
Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for...
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext...
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over...
Tata Elxsi, DENSO and AAtek Inaugurate ‘Robotics and Automation Innovation Lab’ in Frankfurt
FRANKFURT, Germany and BENGALURU, India, Nov. 20, 2024 /PRNewswire/ -- Tata Elxsi, a global leader in design and technology services,...
Forging New Paths: Alfasigma Group and Fangzhou Inc. Chart a Course for Internet Healthcare
SHANGHAI, Nov. 19, 2024 /PRNewswire/ -- On November 13th, a high-level delegation from the Alfasigma Group, led by Mr. Andriy...
Global Drug Discovery Technologies Market Projected to Reach $197 Billion by 2029
Revolutionizing Drug Research: AI and Genomics Drive Faster, More Successful Drug Discovery for Life-Saving Treatments BOSTON, Nov. 19, 2024 /PRNewswire/...
SAS forecasts AI reality over hype for health care and life sciences in 2025
Pharma and health care industries take deliberate steps, not leaps, toward AI innovation and digital transformation CARY, N.C., Nov. 19,...
Roche Canada Announces New Informatics Jobs in Ontario’s Life Sciences Sector
These jobs will propel the province towards being a global leader in biomanufacturing and life sciences MISSISSAUGA, ON, Nov. 19,...
Vee Healthtek Joins TA Associates’ Portfolio with Strategic Growth Investment
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Today, TA Associates ("TA"), a global growth private equity firm, has announced a majority stake...
World-Class Leaders to Headline HIMSS25 Global Conference
LAS VEGAS, Nov. 19, 2024 /PRNewswire/ -- Informa Markets announced an exceptional lineup of keynote speakers for the 2025 HIMSS...
Cmbio: A New Brand Unifying Leaders in Microbiome and Metabolomics Science
COPENHAGEN, Denmark, Nov. 19, 2024 /PRNewswire/ -- Today marks the launch of Cmbio, a new brand that brings together Clinical Microbiomics...
ACTO JOINS VEEVA AI PARTNER PROGRAM TO STRENGTHEN FIELD TEAM MESSAGING DURING FACE-TO-FACE HCP INTERACTIONS
Helping Mutual Customers Elevate the "Human Touch" Element of Their Omnichannel Engagement Strategies MADRID, Nov. 19, 2024 /PRNewswire/ - Veeva Commercial...
Axtria Unveils New Benchmarking Study on Territory Design and Refinement for Life Sciences Companies
Reveals latest trends in territory alignment, balancing workloads, and enhancing sales effectiveness that can help reshape, inform, and modernize commercial...
Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”
Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription...
Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate
Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK,...
Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia’s First Cardiac Gene Therapy Trial for Heart Failure
Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for...
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
--Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio...
AMCOR AND BERRY TO COMBINE IN AN ALL-STOCK TRANSACTION, CREATING A GLOBAL LEADER IN CONSUMER AND HEALTHCARE PACKAGING SOLUTIONS
Combination of Complementary Businesses Expands Product Offering and Capabilities to Support Higher Growth for Customers Combined R&D and Innovation Investment...
LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024...